Oregon could expand Rx drug benefit

24 September 2006

The US state of Oregon will, in addition to holding its mid-term elections for State Governor and the US House of Representatives on November 7, be putting an initiative to voter approval on expanding the Pacific coastal state's prescription drug program to cover all residents who do not otherwise have drug coverage, according to local media reports.

The Oregon Drug Program is presently restricted to residents aged 55 or over, whose incomes are below $18,130 and have not had coverage for at least six months. The proposition would affect 600,000 people if carried.

"Pharma lobby thwarted" earlier scheme

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight